Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

PHASE3CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
Helicobacter Pylori Infection
Interventions
DEVICE

Dual Mode BreathID Hp System

The Dual Mode Breath ID Hp System consists of breath collection bags, a 13C-labelled substrate (urea) and a breath analyzer device

Trial Locations (13)

11040

Digestive Disease Care, New Hyde Park

20815

Metropolitan Gastro Group, Chevy Chase

33016

Palmetto Research, Hialeah

34741

Hope Clinical Research, Kissimmee

44094

Great Lakes Medical Research, Willoughby

49519

Gasrtrenetrology Associates of Western Michigan, West Michigan Clinical Research Center, Wyoming

57701

Innovative Clinical Research, Rapid City

70300

Assaf Harofe Medical Center, Tzrifin

78215

Digestive Disease Center of South Texas, P.L.L.C, San Antonio

80026

Innovative Clincal Research, Lafayette

85710

Del Sol Research Management, Tucson

93003

Ventura Clinical Trials, Ventura

7830604

Barzilai Medical center, Ashkelon

Sponsors
All Listed Sponsors
lead

Meridian Bioscience, Inc.

INDUSTRY